Get started
revilo1987

ATOS - Top Testing ?

Long
Atossa Therapeutics, Inc. (NASDAQ:ATOS)  
revilo1987  
NASDAQ:ATOS   Atossa Therapeutics, Inc.
Trend Lines
2
0
trendline
Will the Top at 2.65 USD be tested or will it go down to 2,0 USD (Volume Point of Control) first?
The most analysts aim for 7.5 USD for end of this year. With the cancer therapies in their portfolio it will be there a lot earlier I think.

Related Ideas

revilo1987
ATOSSA Therapeutics - Absorption / sideways and then strong buy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.